Target intelligence / Profile preview

Novel transcript, antisense to phospholipase C gamma 2 (LOC124903731)

Target
LOC124903731
Molecular classification
Long non-coding RNA (lncRNA), Non-coding RNA
01

Overview

LOC124903731 represents a predicted or novel transcript classified as a long non-coding RNA that is transcribed antisense to the coding region of the phospholipase C gamma 2 (PLCG2) gene. There are no authoritative reports describing protein-coding potential, molecular mechanism, biological function, clinical significance, or its consideration as a therapeutic or diagnostic target. Its name and annotation suggest it may play a regulatory or as-yet-undiscovered role in gene expression modulation of PLCG2, but direct evidence is absent in curated databases or the literature. Phospholipase C gamma 2 (PLCG2, ENSG00000197943) is a well-studied therapeutic enzyme target, but "novel transcript, antisense to PLCG2" (LOC124903731) is a distinct, uncharacterized non-coding RNA with no evidence for target status. The provided identifiers appear mismatched or possibly mistaken, as neither ENSG00000303013 nor LOC124903731 are established gene or protein entries in curated biomedical resources. If you intended to query about PLCG2 (the enzyme), please clarify, as comprehensive information exists for that gene and protein. For the transcript specified, there is currently insufficient information to classify it as a molecular target, associated disease gene, or druggable entity.

Other names
LOC124903731Novel transcript, antisense to PLCG2

Beyond the preview

Go deeper on Novel transcript, antisense to phospholipase C gamma 2 (LOC124903731).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to phospholipase C gamma 2 (LOC124903731).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call